Dr. Martens plc (LON:DOCS) has announced the appointment of Berenberg as joint corporate broker, to work alongside Investec and Goldman Sachs, with immediate effect.
Dr. Martens appoints Berenberg as Joint Corporate Broker
- Written by: Amilia Stone
Latest Company News
Dr. Martens has appointed Alia Gogi as an Independent Non-Executive Director, effective 1 September 2026, with committee appointments also confirmed.
Dr. Martens plc has appointed Berenberg as a joint corporate broker with immediate effect, working alongside Investec and Goldman Sachs.
Dr. Martens has signed a distribution deal with Beside Group to enter the UAE market for the first time and partnered with Crosby in Latin America, which has opened stores in Argentina and Chile.
Trading since the start of FY26 has met expectations across channels. Americas DTC saw strong full-price sales while APAC, notably South Korea, delivered robust growth; EMEA DTC, particularly the UK, remains challenging.
Dr. Martens plc shares strong preliminary results for FY25, outlining a strategic roadmap—Levers For Growth—aimed at returning to profit growth and elevating brand desirability.
Dr. Martens (LON:DOCS) reports first half results aligning with expectations, highlighting strategic progress in marketing, cost reduction, and U.S. growth.
